Performance evaluation of the UMIC® Cefiderocol to determine MIC in Gram-negative bacteria
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Performance evaluation of the UMIC® Cefiderocol to determine MIC in Gram-negative bacteria
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2023-05-21
DOI
10.1093/jac/dkad149
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales
- (2023) Keith S. Kaye et al. Infectious Diseases and Therapy
- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
- (2022) Christopher JL Murray et al. LANCET
- Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant enterobacterales
- (2022) Rémy A. Bonnin et al. CLINICAL MICROBIOLOGY AND INFECTION
- Nosocomial outbreak by NDM-1-producing Klebsiella pneumoniae highly resistant to cefiderocol, Florence, Italy, August 2021 to June 2022
- (2022) Marco Coppi et al. Eurosurveillance
- In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium
- (2022) Saoussen Oueslati et al. Antibiotics-Basel
- In Vitro Susceptibility of Gram-Negative Pathogens to Cefiderocol in Five Consecutive Annual Multinational SIDERO-WT Surveillance Studies, 2014 to 2019
- (2021) James A. Karlowsky et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin resistance in Gram-negative bacteria analysed by five phenotypic assays and inference of the underlying genomic mechanisms
- (2021) Diana Albertos Torres et al. BMC MICROBIOLOGY
- Performance of commercial methods for linezolid susceptibility testing of Enterococcus faecium and Enterococcus faecalis
- (2020) Loren Dejoies et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cefiderocol Antimicrobial Susceptibility Testing Considerations: The Achilles Heel of the Trojan Horse?
- (2020) Patricia J. Simner et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Cefiderocol Antimicrobial Susceptibility Testing against Multidrug-Resistant Gram-negative Bacilli: A Comparison of Disk Diffusion to Broth Microdilution
- (2020) C. Paul Morris et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options
- (2019) Chau-Chyun Sheu et al. Frontiers in Microbiology
- Reproducibility of broth microdilution MICs for the novel Siderophore cephalosporin, Cefiderocol, determined using Iron-depleted cation-adjusted Mueller-Hinton broth
- (2019) Meredith A. Hackel et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Unravelling ceftazidime/avibactam resistance of KPC-28, a KPC-2 variant lacking carbapenemase activity
- (2019) Saoussen Oueslati et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Siderophore Cephalosporin Cefiderocol Utilizes Ferric Iron Transporter Systems for Antibacterial Activity againstPseudomonas aeruginosa
- (2016) Akinobu Ito et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae
- (2016) Ritu Banerjee et al. Virulence
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now